Roivant Sciences Ltd.
ROIV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001635088
In the last 90 days, Roivant Sciences Ltd. insiders filed 0 open-market purchases and 8 sales; 500 institutions reported holding it in 13F filings for Q2 2026, worth $19.7B in total; 3 superinvestors hold it, including Viking Global Investors and Maverick Capital.
13F holders, Q4 2023
Institutional positions in Roivant Sciences Ltd. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 225
- +19 vs. Q3 2023
- Shares held
- 541.6M
- −2.80M (−0.5%) vs. Q3 2023
- Total value
- $6.08B
- −$277.1M (−4.4%) vs. Q3 2023
- New holders
- 60
- 86 more added
- Sold out
- 41
- 53 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ROIV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 500 | $19.7B |
| Q1 2026 | 445 | $14.7B |
| Q4 2025 | 400 | $11.0B |
| Q3 2025 | 338 | $7.59B |
| Q2 2025 | 339 | $5.80B |
| Q1 2025 | 314 | $5.63B |
| Q4 2024 | 320 | $6.65B |
| Q3 2024 | 294 | $6.57B |
| Q2 2024 | 294 | $5.77B |
| Q1 2024 | 259 | $5.60B |
| Q4 2023 | 225 | $6.08B |
| Q3 2023 | 207 | $6.38B |
| Q2 2023 | 182 | $5.03B |
| Q1 2023 | 147 | $3.39B |
| Q4 2022 | 110 | $3.29B |
| Q3 2022 | 78 | $1.19B |
| Q2 2022 | 71 | $1.47B |
| Q1 2022 | 52 | $1.72B |
| Q4 2021 | 42 | $3.42B |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Roivant Sciences Ltd.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pictet Asset Management Holding SA | 2,716,218 | $30.5M | 0.03% | +600,513+28.4% | Added |
| First Trust Advisors LP | 2,739,438 | $30.8M | 0.03% | +2,227,192+434.8% | Added |
| BVF Inc | 2,742,409 | $30.8M | 0.77% | 00.0% | Unchanged |
| Citadel Advisors LLC | 3,481,703 | $39.1M | 0.04% | +3,355,500+2,658.8% | Added |
| Norges Bank | 3,695,967 | $41.5M | 0.01% | +1,175,910+46.7% | Added |
| Price T Rowe Associates Inc | 3,786,613 | $42.5M | 0.01% | +74,131+2.0% | Added |
| Avoro Capital Advisors LLC | 4,651,162 | $52.2M | 0.72% | 00.0% | Unchanged |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $54.3M | 6.46% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 5,275,000 | $59.2M | 0.12% | −925,000−14.9% | Reduced |
| Geode Capital Management, LLC | 5,524,576 | $62.1M | 0.01% | +306,396+5.9% | Added |
| Woodline Partners LP | 6,151,767 | $69.1M | 0.75% | −1,022,486−14.3% | Reduced |
| Vanguard Group Inc | 7,075,651 | $79.5M | 0.00% | +1,473,085+26.3% | Added |
| Farallon Capital Management, L.L.C. | 7,336,000 | $82.4M | 0.52% | +3,482,600+90.4% | Added |
| Baker Bros. Advisors LP | 7,593,024 | $85.3M | 0.97% | −4,284,147−36.1% | Reduced |
| Two Seas Capital LP | 8,508,223 | $95.5M | 23.54% | +592,991+7.5% | Added |
| Patient Square Capital LP | 12,639,920 | $141.9M | 77.60% | 00.0% | Unchanged |
| Wellington Management Group LLP | 13,640,416 | $153.2M | 0.03% | −1,202,560−8.1% | Reduced |
| State Street Corp | 13,727,418 | $154.2M | 0.01% | +3,406,626+33.0% | Added |
| Rubric Capital Management LP | 19,000,000 | $213.4M | 7.96% | +8,500,000+81.0% | Added |
| BlackRock Inc. | 20,805,601 | $233.6M | 0.01% | +3,082,064+17.4% | Added |
| Morgan Stanley | 21,927,044 | $246.2M | 0.02% | +2,615,413+13.5% | Added |
| FMR LLC | 36,976,248 | $415.2M | 0.03% | −1,934,377−5.0% | Reduced |
| Viking Global Investors LPSuperinvestorViking Global Investors | 69,368,961 | $779.0M | 2.85% | −4,065,340−5.5% | Reduced |
| SB Investment Advisers (UK) Ltd | 73,031,667 | $820.1M | 7.30% | 00.0% | Unchanged |
| QVT Financial LP | 112,541,536 | $1.26B | 76.36% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −10,649,397−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −3,819,456−100.0% | Sold out |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 0 | $0 | 0.00% | −2,448,579−100.0% | Sold out |
| Davidson Kempner Capital Management LP | 0 | $0 | 0.00% | −2,000,000−100.0% | Sold out |
| ING Groep NV | 0 | $0 | 0.00% | −1,831,700−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −1,678,159−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,604,487−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −1,503,302−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −1,200,000−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −1,081,767−100.0% | Sold out |
| Bank of Nova Scotia | 0 | $0 | 0.00% | −978,315−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −914,023−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −450,000−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −446,023−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −416,667−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −282,414−100.0% | Sold out |
| Empowered Funds, LLC | 0 | $0 | 0.00% | −264,661−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −219,500−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −204,056−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −172,925−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −172,397−100.0% | Sold out |
| ArrowMark Colorado Holdings LLC | 0 | $0 | 0.00% | −166,260−100.0% | Sold out |
| Chartwell Investment Partners, LLC | 0 | $0 | 0.00% | −102,783−100.0% | Sold out |
| VGI Partners Ltd | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −79,694−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −71,687−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −60,283−100.0% | Sold out |
| CIBC World Markets Inc. | 0 | $0 | 0.00% | −47,181−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −34,583−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −15,782−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,532−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −10,407−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −9,999−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −5,472−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −5,078−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Financial Synergies Wealth Advisors, Inc. | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Decheng Capital Management III (Cayman), LLC | – | – | – | – | Not filed |